HALO logo
halo search icon
SFA
Sopharma AD

SFA · Sopharma AD

2.08

BGN
0.01 (0.483%)
24/08/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

BGN1.12B

PE

28.40

EV/EBITDA

21.4

DIV Yield

1.8%

Payout Ratio

50%

MQV Rating

5Very Weak

As at 24/08/2026 12:00:00 AM

Price Chart

Description

Sopharma AD engages in the provision of pharmaceutical business. Its operations include production and marketing of medical products, medicinal substances as well as dosage forms. It also involved in research, engineering, and implementation activities in the field of phytochemistry, chemistry, and pharmacy. The firm offers dermatological products, gastroenterological, as well as psychoneurological, antiallergic and others. The company was founded in 1933 and is headquartered in Sofia, Bulgaria.

  • All-Companies
  • Extreme Overbought
  • HALO 100
  • HALO 50
  • HALO All
  • Near 52 Week High
  • Near Resistance

Key Fundamentals

EPS 3 yr Growth

92.80%

EBITDA Margin

7.60%

Operating Cashflow

€12m

Free Cash Flow Return

2.10%

ROIC

12.10%

Interest Coverage

6.80

Quick Ratio

0.70

Performance

52 weeks range

Low 1.25 - 2.08

Trade Value (12mth)

US$27,250.00

1 week

6.7%

1 month

8.95%

YTD

44.76%

1 year

63.25%

All time high

3.78

Additional Data

Shares Outstanding (Fully Diluted)

551m

HALO Sector

Healthcare

Next Company Report Date

01-Feb-27

Next Ex Dividend Date

09-Jul-26

Next Dividend Pay Date

24-Aug-26

Reporting Currency

EUR

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Strong

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

Key Stakeholders

NameTitle
Donev Investments AdPrivate Company
Telecomplect ADPrivate Company
Ognian Ivanov DonevIndividual
Sopharma ADPublic Company
Alexander Viktorov ChaushevIndividual

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Sopharma AD (SFA:BUL)?
Halo FAQ
The current share price of Sopharma AD (SFA:BUL) is BGNлв2.08.
2
What is the 52-week high share price for Sopharma AD (SFA:BUL)?
Halo FAQ
The 52-week high share price for Sopharma AD (SFA:BUL) is BGNлв2.08.
3
What is the 52-week low share price for Sopharma AD (SFA:BUL)?
Halo FAQ
The 52-week low share price for Sopharma AD (SFA:BUL) is BGNлв1.25.
4
What is the dividend yield for Sopharma AD (SFA:BUL)?
Halo FAQ
The current TTM dividend payout for Sopharma AD (SFA:BUL) is 1.80.
5
What was Sopharma AD (SFA:BUL) last dividend payment?
Halo FAQ
The last dividend payment of Sopharma AD (SFA:BUL) is BGNлв0.05.
6
What is the franking level for Sopharma AD (SFA:BUL)?
Halo FAQ
Sopharma AD (SFA:BUL) has a franking level of 0.00%.
7
In which sector is Sopharma AD (SFA:BUL) classified?
Halo FAQ
Sopharma AD (SFA:BUL) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for Sopharma AD (SFA:BUL)?
Halo FAQ
The current P/E ratio for Sopharma AD (SFA:BUL) is 28.40.